Fierce Pharma

APRIL 18, 2024

Novo Nordisk is receiving pushback from a trio of lawmakers over its decision to discontinue its long-acting insulin product Levemir, which was due for a steep discount at the start of the new year | Novo Nordisk is receiving pushback from a trio of lawmakers on its decision to discontinue its long-acting insulin product Levemir, which was due for (..)

Insulin 129

Insulin Production 129

Bio Pharma Dive

JULY 29, 2021

An injectable insulin from Viatris has become the first-ever biosimilar product that can be directly substituted for a marketed biologic, a long-awaited decision that could put pricing pressure on other diabetes drugs.

FDA Approval 321

FDA Approval Insulin Production Marketing 321

XTalks

FEBRUARY 18, 2025

The FDA has approved Sanofis Merilog (insulin-aspart-szjj) as the first rapid-acting insulin biosimilar product for the treatment of diabetes. Merilog is a biosimilar to Novo Nordisks NovoLog, a widely used rapid-acting insulin aspart. Insulin, a hormone produced by the pancreas, allows glucose to enter cells for energy.

Insulin 59

Insulin FDA Approval Production Hormones 59

pharmaphorum

APRIL 13, 2022

The treatment has been around for over a century but insulin has still become the centre of the ongoing discussion over pricing of pharmaceutical products. Ben Hargreaves looks at why insulin’s price is so controversial and whether this could be set to change. Insulin rationing. In the US, approximately 37.3

Insulin 130

Insulin Drugs Production Hormones 130

STAT News

MARCH 1, 2023

Eli Lilly, one of the largest makers of insulin, said Wednesday it would make dramatic cuts to the prices of several of its older insulin products in an effort to lower costs for consumers whose insulin is not fully paid for by insurance. The moves come amid a public and political uproar over the price of insulin.

Insulin 98

Insulin Production 98

XTalks

NOVEMBER 4, 2024

Cure Research: Moving Toward an Insulin-Free Future JDRF is focused on funding research that is accelerating the development of new treatments for people with T1D — for all ages and stages. “Our before people need insulin therapy), so that it’s possible to intervene with therapies that can stop clinical disease before it starts.”

Insulin 108

Insulin Research Medicine Doctor 108

pharmaphorum

JANUARY 13, 2023

The ‘big three’ insulin producers Novo Nordisk, Eli Lilly, and Sanofi are being sued by the state of California for allegedly working together to set artificially inflated prices for their products. Lilly introduced a $35 per month cap on insulin co-pays in 2020, with Sanofi pledging a $35 cap last year.

Insulin 105

Insulin Manufacturing Production Drugs 105

STAT News

MARCH 1, 2023

Have a smashing day … Eli Lilly, one of the largest makers of insulin, maintained it would make dramatic cuts to the prices of several of its older insulin products in an effort to lower costs for consumers whose insulin is not fully paid for by insurance , STAT reports.

Insulin 98

Insulin Production 98

Fierce Pharma

MARCH 22, 2024

With a positive recommendation from Europe’s Committee for Medicinal Products for Human Use (CHMP), Novo has come a step closer to bringing its revolutionary Awiqli (once weekly basal insulin icodec) to the market. But that doesn’t mean the Danish company has moved on from its previous generation of blood sugar modulators.

Insulin 127

Insulin Sales Medicine Production 127

pharmaphorum

APRIL 29, 2022

For many patients with type 2 diabetes, having to inject basal insulin every day is a burdensome fact of life, but Novo Nordisk is trying to change that. cases of hypoglycaemia per year with insulin icodec, versus 0.27 In absolute terms, there were 0.73 events for the once-daily drug.

Insulin 98

Insulin Trials Drugs Production 98

pharmaphorum

JULY 29, 2021

Generic drugmaker Mylan has become the first company to secure FDA approval for a biosimilar product that is considered completely interchangeable with the reference product – namely Sanofi’s once-daily insulin Lantus.

Insulin 98

Insulin Drugs Production Generic Drugs 98

pharmaphorum

JULY 14, 2021

Eli Lilly bought a stake in Protomer Technologies and its glucose-sensing insulin platform last year, and it must like what it has seen in the programme since then – it has just agreed to buy the company outright. . It was also responsible for the first recombinant insulin product – Humulin – which launched in 1982 and remains on sale.

Insulin 98

Insulin Protein Production Development 98

STAT News

OCTOBER 6, 2022

The three companies that dominate the global market for insulin have launched various programs to expand the reach of their medicines in dozens of low and middle-income countries — but their efforts remain patchy and equitable access consequently remains out of reach, according to a new analysis.

Insulin 111

Insulin Regulation Manufacturing Medicine 111

XTalks

NOVEMBER 15, 2022

In Lilly’s case, the fake account claimed the company was giving out free insulin. A fraudulent Eli Lilly account with the username @EliLillyandCo tweeted a message on November 10 that said: “We are excited to announce insulin is free now.”. On average, it is estimated that insulin costs about $98.70 percent, or by $16.08

Insulin 97

Insulin Sales Branding Production 97

pharmaphorum

NOVEMBER 11, 2022

In addition to the financial hit, the stunt has only served to draw attention to Lilly’s role in the insulin pricing crisis in the United States, where multiple patients have died because of rationing unaffordable insulin. That’s why other insulin stocks are falling too. Happy Disability Awareness Month.

Insulin 98

Insulin Branding Production Marketing 98

STAT News

MARCH 14, 2023

list prices for several insulin products by up to 75%, the latest big drugmaker to take such a step in response to a years-long outcry over the cost of the diabetes treatments. The company plans to cut the list price of its NovoLog insulin by 75%, and the prices for Novolin and Levemir by 65% starting in January 2024.

Insulin 98

Insulin Branding Production Drugs 98

STAT News

MARCH 9, 2023

Now that Eli Lilly is cutting prices on some of its insulin products, Sen. This week, he introduced a bill that would place a $20 cap on all insulin, a move designed to drastically lower costs for millions of Americans. Bernie Sanders (I-Vt.) is seeking to build on that momentum.

Insulin 98

Insulin Production Manufacturing Drugs 98

BioSpace

JUNE 6, 2022

Sernova shared positive Phase I/II data from an ongoing clinical study of its implantable Cell Pouch device that showed evidence of in vivo active insulin production.

Insulin 100

Insulin In-Vivo Production 100

Drug Channels

SEPTEMBER 15, 2023

Nicole summarizes MMIT’s research on payers’ views of two crucial market changes: (1) the Inflation Reduction Act of 2022’s requirement to cap insulin prices at $35 for Medicare beneficiaries, and (2) manufacturers’ reduction in list prices for certain insulin products.

Insulin 97

Insulin Manufacturing Drugs Research 97

Pharmaceutical Technology

MARCH 1, 2023

In the last few years, there have been growing calls to onshore the manufacturing of certain pharma products, including active pharmaceutical ingredients (API), to ensure a smooth supply and to minimise shortages in the European Union (EU). You can also subscribe here to receive email notifications when a new issue is available.

Production 130

Production Insulin FDA Approval Pharma Production 130

STAT News

MARCH 14, 2023

list prices for several insulin products by up to 75%, the latest big drugmaker to take such a step in response to a years-long outcry over the cost of the diabetes treatments , STAT writes. The … Under mounting pressure, Novo Nordisk plans to cut U.S.

Insulin 98

Insulin Production Branding 98

Scienmag

JUNE 7, 2021

Credit: ETH Zurich Many modern fitness trackers and smartwatches feature integrated LEDs. The green light emitted, whether continuous or pulsed, penetrates the skin and can be used to measure the wearer’s heart rate during physical activity or while at rest. These watches have become extremely popular.

Insulin 95

Insulin Production Research Gene Therapy 95

STAT News

MARCH 16, 2023

Following the lead of its rivals, Sanofi will cut the price of its most widely prescribed insulin in the U.S. The change comes after Eli Lilly and then Novo Nordisk announced plans this month to reduce list prices for some of their own insulin products by similar amounts. The moves will go into effect on Jan.

Insulin 98

Insulin Manufacturing Production Marketing 98

XTalks

JULY 3, 2023

The treatment is derived from deceased donor pancreatic cells and is indicated for patients who are unable to achieve average blood glucose levels (glycated hemoglobin) with daily insulin injections or with continuous infusion through a pump because of repeated episodes of severe hypoglycemia (low blood sugar).

Insulin 98

Insulin Gene Therapy Gene Regulation 98

STAT News

MARCH 3, 2023

… Now that Eli Lilly slashed the price for some of its insulin products, the moves raised questions about what will happen to other efforts to provide low-cost insulin, Kaiser Health News explains. plans to sell low-cost insulin. plans to sell low-cost insulin. And the Mark Cuban Cost Plus Drug Co.

Insulin 98

Insulin Drugs Production Marketing 98

XTalks

SEPTEMBER 23, 2020

Being hailed as the world’s shortest and thinnest needle for insulin injection, Droplet Micron has recently been introduced into the pen needle market by HTL (High Tech Lab)-STREFA, Inc. These are important feature innovations for those that depend on insulin injections. The new and innovative needle measures at just 34G x 3.5mm.

Insulin 98

Insulin Marketing Drug Delivery Compliance 98

Scienmag

MAY 17, 2022

Well known for their applications in the production of therapeutic proteins like insulin, plasmids are broadly used in the large-scale production of many bioproducts. These small, circular DNA molecules are used by scientists to introduce new genes into a target organism. Credit: CABBI Plasmids have extensive […].

Production 90

Production Insulin Development DNA 90

Fierce Pharma

FEBRUARY 8, 2024

The company will provide its insulin products at $35 per month and donate free insulin at 15 clinics over the next five years. After reaching a settlement with Minnesota’s attorney general, Eli Lilly can close the book on a yearslong lawsuit in the state. |

Insulin 86

Insulin Production 86

Pharmaceutical Commerce

SEPTEMBER 21, 2023

Deal aims to provide diabetes treatment to patients across the continent.

Insulin 105

Insulin Production 105

Scienmag

JUNE 21, 2022

Diabetes is a lifelong, chronic health condition caused by abnormalities in the body’s production and use of the hormone insulin. Research has shown that the feel-good hormone, dopamine (DA), plays a key role in how the body regulates the production of insulin.

Insulin 72

Insulin Regulation Hormones Production 72

Fierce Pharma

AUGUST 17, 2023

million settlement that would get Eli Lilly out of hot water over claims it jacked up the price of its lucrative insulin product Humalog. | million settlement unless it’s altered to make sure states can still file their own insulin pricing lawsuits. Nine states are saying not so fast to a proposed $13.5

Insulin 79

Insulin Production 79

Pharmaceutical Technology

FEBRUARY 24, 2023

(LAI-287 + semaglutide) overview A fixed dose combination of GLP-1 analogue semaglutide and LAI-287, long-acting basal insulin is under development for the treatment of type 2 diabetes. The drug candidate is administered as an subcutaneous formulation.The combination acts by targeting GLP-1R and insulin receptor.

Insulin 182

Insulin Hormones Drugs Clinical Trials 182

Drug Channels

JANUARY 10, 2023

Each exclusion list now contains about 600 products. Below, I highlight four takeaways from this year’s lists, including a look at biosimilar insulin and the forthcoming biosimilar competition for Humira.

Insulin 98

Insulin Pharmacy Containment Drugs 98

STAT News

MARCH 17, 2023

Enjoy, and see you soon … Following the lead of its rivals, Sanofi will cut the price of its most widely prescribed insulin in the U.S. The three companies are the largest manufacturers of insulin and collectively hold a dominant 80% share of the market. Continue to STAT+ to read the full story…

Insulin 98

Insulin Research Drugs Manufacturing 98

The Pharma Data

JULY 29, 2021

Food and Drug Administration approved the first interchangeable biosimilar insulin product, indicated to improve glycemic control in adults and pediatric patients with Type 1 diabetes mellitus and in adults with Type 2 diabetes mellitus. for the treatment of diabetes. Biosimilars marketed in the U.S.

Insulin 52

Insulin Production FDA Approval Generic Drugs 52

Medical Xpress

JANUARY 25, 2023

A new study from researchers at Laval University in Quebec, Canada, shows that genetically increasing omega-3 fatty acid production, without direct gut microbiota contact, improves the balance of insulin and glucagon (glucose balance) in obese mice.

Production 90

Production Insulin Genetics Research 90

Camargo

OCTOBER 14, 2020

Multiple guidance documents have been released in the last several years outlining the FDA’s current thinking on specific digital health products, such as software as a medical device (SaMD) and mobile medical applications. ANDA applications rely on an approved product, provided in the FDA’s Orange Book as the Reference Listed Drug (RLD).

Development 196

Development Insulin Drug Delivery Production 196